9:00 | Login & warm-up

9:30 | Introduction: Agnès Legoll, BioValley France & BIOPRO Baden-Württemberg

9:45 | Prof. Dr. Christophe Borg – CHRU Besançon Oncologie Médicale (keynote 1)
«Characterization and immunomodulation of tumor infiltrating lymphocytes in gastrointestinal cancers»

10:15 | Dr. Frank Schwöbel – Immatics Biotechnologies, Tübingen (keynote 2)
«Targeting of Tumor-specific HLA Ligands with Bispecific T cell Engaging Receptor (TCER™) Molecules»

10:45 | Dr. Nicolas Basse – Sanofi ​​​​
«A focused Platforms and Pathways approach to support Immuno-Oncology Pipeline»

11:00 | ​Prof. Dr. Susanne Bailer – Fraunhofer IGB, Stuttgart
«TheraVision – Platform technology for the development, production and testing of oncolytic viruses»

11:15 | Coffee Break​​​​​​​​​​​​​​

11:30 | Dr. Jean-Marc Balloul – Transgene
«​​​​​​​Oncolytic virotherapy, a novel class of multifunctional immunotherapeutics»

11:45 | Short Presentation Session

12:30 | Networking

13:30 | Lunch Break

14:00 | ​​​​​​​​​​Prof. Dr. Kerstin Otte – Hochschule Biberach (HBC), Biberach
«Cell line development: novel concepts for optimized protein production»

14:15 | Dr. Albin Jeanne – Apmonia Therapeutics
«​​​​​​​Targeting the tumor microenvironment through innovative and personalized peptide-based strategies»

14:30 | Dr. Michael Burnet – Synovo, Tübingen
«​​​​​​​Immuno-oncology models and effects of micro-environment modulators»

14:45 | Dr. Jessica Matta – Odimma
«​​​​​​​Active Personalized Cancer Immunotherapy»

15:00 | Coffee Break​​​​​​​​​​​​​​

15:15 | Dr. Martin Steiner – Synimmune, Tübingen
«​​​​​​​Optimized mono- and bispecific antibodies for treatment of AML»

15:30 | Prof. Dr. Céline Mascaux – Hôpitaux Universitaires de Strasbourg, Thoracic oncology
«​​​​​​​Immune evasion as a target in lung cancer: to treat, to cure and to prevent»

15:45 | Networking

17:00 | End of event